收藏切换
Interpretation to the 2023 clinical consensus statement for definition, epidemiology, management and prevention by the Heart Failure Association of the European Society of Cardiology
收藏切换
Yanan ZHANG, Siriguleng*, Hongxin YANG, Xiaobin GUO
World Clinical Drug | 2023, 44(10) : 1017 - 1021
Less
收藏切换
World Clinical Drug | 2023, 44(10): 1017-1021
• Topic •
Interpretation to the 2023 clinical consensus statement for definition, epidemiology, management and prevention by the Heart Failure Association of the European Society of Cardiology
Full
Yanan ZHANG, Siriguleng*, Hongxin YANG, Xiaobin GUO
Affiliations
  • Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China
Published: 2023-10-10 doi: 10.13683/j.wph.2023.10.001
Outline
收藏切换

The deterioration of chronic heart failure (CHF) not only reduces the quality of life of patients, increases the risk of hospitalization and death, but also imposes a heavy burden on healthcare resources. In order to better manage CHF, the Heart Failure Association of the European Society of Cardiology has developed a new clinical consensus statement in 2023, updating the definition, clinical characteristics, management, and prevention of CHF deterioration. The consensus highlights the importance of diuretics, and intravenous, oral or combined diuretics should be selected depending on the severity of the patient. It also emphasizes the importance of early and rapid administration of guideline recommended medical therapies to prevent first deterioration and repeated exacerbations of heart failure. In order to relieve the medical pressure and meet the needs of patients for timely treatment, it is recommended to carry out hierarchical diagnosis and treatment for patients, mild to moderate patients in emergency or outpatient treatment, severe patients need to choose hospital treatment. This article provided a brief interpretation of the relevant content in order to provide reference for the clinical management of CHF.

chronic heart failur  /  deterioration of heart failure  /  diuretics  /  drug therapy  /  prevention  /  graded diagnosis and treatment
张亚男, 斯日古楞, 杨宏昕, 郭小彬. 2023欧洲心脏病学会心力衰竭协会《临床共识声明:慢性心力衰竭恶化的定义、流行病学、管理和预防》解读. 世界临床药物, 2023 , 44 (10) : 1017 -1021 . DOI: 10.13683/j.wph.2023.10.001
Yanan ZHANG, Siriguleng, Hongxin YANG, Xiaobin GUO. Interpretation to the 2023 clinical consensus statement for definition, epidemiology, management and prevention by the Heart Failure Association of the European Society of Cardiology[J]. World Clinical Drug, 2023 , 44 (10) : 1017 -1021 . DOI: 10.13683/j.wph.2023.10.001
Year 2023 volume 44 Issue 10
17
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.10.001
  • Receive Date:2023-06-29
  • Online Date:2026-11-18
  • Published:2023-10-10
Article Data
Affiliations
History
  • Received:2023-06-29
Funding
Affiliations
    Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.10.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT